Initial Evidence for Brain Plasticity Following a Digital Therapeutic Intervention for Depression.

Autor: Hoch MM; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Psychology, University of California, Los Angeles, Los Angeles, CA, USA., Doucet GE; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Moser DA; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Hee Lee W; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Collins KA; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Huryk KM; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Psychology, Fairleigh Dickinson University, Teaneck, NJ, USA., DeWilde KE; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Albert Einstein College of Medicine, Bronx, NY, USA., Fleysher L; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Iosifescu DV; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Psychiatry, NYU School of Medicine, New York, NY, USA.; Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, USA., Murrough JW; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Charney DS; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Frangou S; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Iacoviello BM; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Click Therapeutics, Inc., New York, NY, USA.

Publikováno v: Chronic stress (Thousand Oaks, Calif.) [Chronic Stress (Thousand Oaks)] 2019 Sep 18; Vol. 3, pp. 2470547019877880. Date of Electronic Publication: 2019 Sep 18 (Print Publication: 2019).

Ketamine Treatment and Global Brain Connectivity in Major Depression.

Autor: Abdallah CG; Clinical Neuroscience Division, VA National Center for PTSD, West Haven, CT, USA.; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA., Averill LA; Clinical Neuroscience Division, VA National Center for PTSD, West Haven, CT, USA.; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA., Collins KA; Mood and Anxiety Disorders Program, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Geha P; Clinical Neuroscience Division, VA National Center for PTSD, West Haven, CT, USA.; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA., Schwartz J; Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Averill C; Clinical Neuroscience Division, VA National Center for PTSD, West Haven, CT, USA.; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA., DeWilde KE; Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Wong E; Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Anticevic A; Clinical Neuroscience Division, VA National Center for PTSD, West Haven, CT, USA.; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.; Department of Psychology, Yale University, New Haven, CT, USA.; Interdepartmenal Neuroscience Program, Yale University School of Medicine, New Haven, CT, USA., Tang CY; Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Iosifescu DV; Mood and Anxiety Disorders Program, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Fishberg Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Charney DS; Mood and Anxiety Disorders Program, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Fishberg Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Murrough JW; Mood and Anxiety Disorders Program, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Fishberg Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Publikováno v: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2017 May; Vol. 42 (6), pp. 1210-1219. Date of Electronic Publication: 2016 Sep 08.

Reduced global functional connectivity of the medial prefrontal cortex in major depressive disorder.

Autor: Murrough JW; Mood and Anxiety Disorders Program, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.; Fishberg Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York.; Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Abdallah CG; Clinical Neuroscience Division, VA National Center for PTSD, West Haven, Connecticut.; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut., Anticevic A; Clinical Neuroscience Division, VA National Center for PTSD, West Haven, Connecticut.; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut., Collins KA; Mood and Anxiety Disorders Program, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York., Geha P; Clinical Neuroscience Division, VA National Center for PTSD, West Haven, Connecticut.; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut., Averill LA; Clinical Neuroscience Division, VA National Center for PTSD, West Haven, Connecticut.; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut., Schwartz J; Mood and Anxiety Disorders Program, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York., DeWilde KE; Mood and Anxiety Disorders Program, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York., Averill C; Clinical Neuroscience Division, VA National Center for PTSD, West Haven, Connecticut.; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut., Jia-Wei Yang G; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut., Wong E; Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York., Tang CY; Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York., Krystal JH; Clinical Neuroscience Division, VA National Center for PTSD, West Haven, Connecticut.; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut., Iosifescu DV; Mood and Anxiety Disorders Program, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.; Fishberg Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York.; Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Charney DS; Mood and Anxiety Disorders Program, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.; Fishberg Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York.; Department of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New York, New York.

Publikováno v: Human brain mapping [Hum Brain Mapp] 2016 Sep; Vol. 37 (9), pp. 3214-23. Date of Electronic Publication: 2016 May 04.

Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial.

Autor: Murrough JW; Mood and Anxiety Disorders Program,Department of Psychiatry,Icahn School of Medicine at Mount Sinai,New York,NY,USA., Soleimani L; Mood and Anxiety Disorders Program,Department of Psychiatry,Icahn School of Medicine at Mount Sinai,New York,NY,USA., DeWilde KE; Mood and Anxiety Disorders Program,Department of Psychiatry,Icahn School of Medicine at Mount Sinai,New York,NY,USA., Collins KA; Mood and Anxiety Disorders Program,Department of Psychiatry,Icahn School of Medicine at Mount Sinai,New York,NY,USA., Lapidus KA; Departments of Psychiatry and Neurobiology,Stony Brook University,Stony Brook,NY,USA., Iacoviello BM; Mood and Anxiety Disorders Program,Department of Psychiatry,Icahn School of Medicine at Mount Sinai,New York,NY,USA., Lener M; Mood and Anxiety Disorders Program,Department of Psychiatry,Icahn School of Medicine at Mount Sinai,New York,NY,USA., Kautz M; Mood and Anxiety Disorders Program,Department of Psychiatry,Icahn School of Medicine at Mount Sinai,New York,NY,USA., Kim J; Deparment of Psychology,UCLA,Los Angeles,CA,USA., Stern JB; Department of Psychology,Drexel University,Philadelphia,PA,USA., Price RB; Department of Psychiatry,University of Pittsburgh School of Medicine,Pittsburgh,PA,USA., Perez AM; Department of Anesthesiology,Icahn School of Medicine at Mount Sinai,New York,NY,USA., Brallier JW; Department of Anesthesiology,Icahn School of Medicine at Mount Sinai,New York,NY,USA., Rodriguez GJ; Department of Psychiatry,Icahn School of Medicine at Mount Sinai,New York,NY,USA., Goodman WK; Department of Psychiatry,Icahn School of Medicine at Mount Sinai,New York,NY,USA., Iosifescu DV; Mood and Anxiety Disorders Program,Department of Psychiatry,Icahn School of Medicine at Mount Sinai,New York,NY,USA., Charney DS; Mood and Anxiety Disorders Program,Department of Psychiatry,Icahn School of Medicine at Mount Sinai,New York,NY,USA.

Publikováno v: Psychological medicine [Psychol Med] 2015 Dec; Vol. 45 (16), pp. 3571-80. Date of Electronic Publication: 2015 Aug 12.

The promise of ketamine for treatment-resistant depression: current evidence and future directions.

Autor: DeWilde KE; Mood and Anxiety Disorders Program, Icahn School of Medicine at Mount Sinai, New York, New York., Levitch CF; Mood and Anxiety Disorders Program, Icahn School of Medicine at Mount Sinai, New York, New York., Murrough JW; Mood and Anxiety Disorders Program, Icahn School of Medicine at Mount Sinai, New York, New York., Mathew SJ; Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas., Iosifescu DV; Mood and Anxiety Disorders Program, Icahn School of Medicine at Mount Sinai, New York, New York.

Publikováno v: Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2015 May; Vol. 1345, pp. 47-58. Date of Electronic Publication: 2015 Feb 03.